These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 20853670)

  • 21. [Use of combined vaccines in children].
    Plebani A
    Ann Ig; 2002; 14(4 Suppl 5):85-91. PubMed ID: 12389297
    [No Abstract]   [Full Text] [Related]  

  • 22. [Intradermal hepatitis B vaccination in workers not responsive to intramuscular vaccination].
    Bauer H; Potasman I; Pick N
    Harefuah; 1998 Mar; 134(6):441-4, 503. PubMed ID: 10909572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth.
    Carniel EF; Morcillo AM; Blotta MH; Da Silva MT; Mazzola TN; Antonio MA; Zanolli ML; Netto AA; Higashi HG; Raw I; Vilela MM
    Vaccine; 2008 Jan; 26(5):647-52. PubMed ID: 18155811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intradermal influenza vaccination--can less be more?
    La Montagne JR; Fauci AS
    N Engl J Med; 2004 Nov; 351(22):2330-2. PubMed ID: 15525715
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of intramuscular and intradermal applications of hepatitis B vaccine in hemodialysis patients.
    Karahocagil MK; Buzgan T; Irmak H; Karsen H; Akdeniz H; Akman N
    Ren Fail; 2006; 28(7):561-5. PubMed ID: 17035164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose sparing with intradermal injection of influenza vaccine.
    Kenney RT; Frech SA; Muenz LR; Villar CP; Glenn GM
    N Engl J Med; 2004 Nov; 351(22):2295-301. PubMed ID: 15525714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose sparing strategy with intradermal influenza vaccination in patients with solid cancer.
    Jo YM; Song JY; Hwang IS; Lee J; Oh SC; Kim JS; Kim SR; Kim WJ; Cheong HJ
    J Med Virol; 2009 Apr; 81(4):722-7. PubMed ID: 19235853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved antibody responses in infants less than 1 year old using intradermal influenza vaccination.
    Sugimura T; Ito Y; Tananari Y; Ozaki Y; Maeno Y; Yamaoka T; Kudo Y
    Vaccine; 2008 May; 26(22):2700-5. PubMed ID: 18436353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice.
    Nicolas JF; Guy B
    Expert Rev Vaccines; 2008 Oct; 7(8):1201-14. PubMed ID: 18844594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study.
    Arnou R; Icardi G; De Decker M; Ambrozaitis A; Kazek MP; Weber F; Van Damme P
    Vaccine; 2009 Dec; 27(52):7304-12. PubMed ID: 19849996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intradermal influenza vaccination in immunocompromized patients is immunogenic and feasible.
    Gelinck LB; van den Bemt BJ; Marijt WA; van der Bijl AE; Visser LG; Cats HA; Rimmelzwaan GF; Kroon FP
    Vaccine; 2009 Apr; 27(18):2469-74. PubMed ID: 19368788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum antibody responses after intradermal vaccination against influenza.
    Belshe RB; Newman FK; Cannon J; Duane C; Treanor J; Van Hoecke C; Howe BJ; Dubin G
    N Engl J Med; 2004 Nov; 351(22):2286-94. PubMed ID: 15525713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity and safety of intradermal influenza vaccination in healthy older adults.
    Chi RC; Rock MT; Neuzil KM
    Clin Infect Dis; 2010 May; 50(10):1331-8. PubMed ID: 20377407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody responses to intradermal recombinant hepatitis B immunization among HIV-positive subjects.
    Ristola MA; Vuola JM; Valle M; von Reyn CF
    Vaccine; 2004 Nov; 23(2):205-9. PubMed ID: 15531038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody responses after dose-sparing intradermal influenza vaccination.
    Auewarakul P; Kositanont U; Sornsathapornkul P; Tothong P; Kanyok R; Thongcharoen P
    Vaccine; 2007 Jan; 25(4):659-63. PubMed ID: 17011678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune response of intradermal hepatitis B vaccination at lower dose versus intramuscular vaccination at double standard dose in predialytic chronic renal failure patients.
    Somboonsilp W; Eiam-Ong S; Tungsanga K; Tirawatanapong T
    J Med Assoc Thai; 2003 Dec; 86(12):1122-7. PubMed ID: 14971519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New vaccination strategies for low- and non-responders to hepatitis B vaccine.
    Rendi-Wagner P; Wiedermann G; Stemberger H; Kollaritsch H
    Wien Klin Wochenschr; 2002 Mar; 114(5-6):175-80. PubMed ID: 12238305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intradermal vaccination against influenza.
    Kilbourne ED
    N Engl J Med; 2005 Mar; 352(10):1044-6; author reply 1044-6. PubMed ID: 15762000
    [No Abstract]   [Full Text] [Related]  

  • 39. Intradermal vaccination against influenza.
    Weller TH
    N Engl J Med; 2005 Mar; 352(10):1044-6; author reply 1044-6. PubMed ID: 15758019
    [No Abstract]   [Full Text] [Related]  

  • 40. Current opportunities and challenges in intradermal vaccination.
    Chen D; Bowersock T; Weeratna R; Yeoh T
    Ther Deliv; 2015; 6(9):1101-8. PubMed ID: 26458019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.